Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Advocacy"

Advocate from Your Office the Week of March 14

Staff  |  March 18, 2011

The ACR is urging the 112th Congress to address many issues important to rheumatology including appropriate reimbursement for specialty care, the repeated battle to avert Medicare payment cuts, funding for the pediatric subspecialty loan repayment program, continued fair reimbursement for dual-energy X-ray absorptiometry scans, and the need for increased research funding.

ACR Meets with CMS Administrator

By Sue Pondrom  |  January 24, 2011

Leadership discusses quality, reimbursement, and medical home

Advancing Rheumatology on Many Fronts

David G. Borenstein, MD  |  December 1, 2010

Presidential priorities for the coming year

2011 Legislative Outlook Important for Rheumatology

From the College  |  December 1, 2010

Next year is shaping up to be an important year for rheumatology on Capitol Hill. Issues that remain unresolved by the last Congress include concerns within the Affordable Care Act, the need for a stable Medicare system with fair physician reimbursement, funding for the pediatric subspecialty loan repayment program, and appropriate reimbursement for specialty care. Most congressional leaders, newly elected or re-elected, know very little about arthritis and other rheumatic diseases. That is why it is critical that rheumatology professionals reach out and educate them on the importance of specialty care and the impact these diseases have on one’s quality of life. 

Arthritis on the Rise

By Sue Pondrom  |  December 1, 2010

CDC notes significant increase in arthritis-attributable activity limitation

DEXA Champion Visits Local Rheumatologist

From the College  |  November 1, 2010

Sen. Blanche Lincoln (D-Ark.) visited the Arthritis Center of the Ozarks in Fayetteville, Ark., in August to speak with local rheumatologist Michael Saitta, MD, to discuss the importance of access to osteoporosis screenings.

Advocating for Arthritis: My First Time on the Hill

Colin C. Edgerton, MD  |  July 1, 2010

Amidst the most momentous week of the year’s tumultuous healthcare reform activities, we arrived in Washington, D.C., for the annual ACR Advocates for Arthritis Capitol Hill Fly-In. This was to be my first visit to Congress. Although my alma mater, Georgetown University, was a short distance from the Capitol dome, as a student I had little interest in the political process—particularly as it related to medicine. Now, however, as a young rheumatologist, I am increasingly aware of the impact health policy has on my daily practice. I have also watched the healthcare reform debate unfold over the last year, recognizing that this is a critical time for physicians to be vocal and active. There is a great deal at stake, and we are surrounded daily by the very issues debated in Washington. Why not take our opinions directly to the decision makers?

The Workforce Today & Tomorrow

Stanley B. Cohen, MD  |  July 1, 2010

The ACR is increasing the ranks of rheumatology on many fronts

In Advocacy, Slow and Steady Wins the Race

From the College  |  April 1, 2010

Earlier in the year, it seemed that healthcare reform was stopped in its tracks because of the Massachusetts Senate special election—which placed Republican Scott Brown in the seat held by the “Liberal Lion,” Edward M. Kennedy. The Senate Democrats lost their supermajority and the momentum to pass President Obama’s healthcare reform legislation subsided. But through strong lobbying by the president, Speaker Nancy Pelosi (D-Calif.), and Senate Majority Leader Harry Reid (D-Nev.), Congress passed the Patient Protection and Affordable Care Act (H.R. 3590)—comprehensive healthcare reform—on March 21, and the president signed the bill into law on March 23.

Call Your Lawmakers the Week of March 15

From the College  |  March 1, 2010

The elimination of consultation code services, the repeated battle to avert Medicare cuts, the need for increased research funding, the creation of a loan repayment program for pediatric rheumatologists, and fair costs for drug therapies are all issues that members of Congress have influence over. All of these issues affect the rheumatology profession, whether you are a clinical practitioner, researcher, academic, or health professional.

  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 30
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences